HighTower Advisors’s Lam Research LRCX Stock Holding History

HighTower Advisors’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-100	Closed	-$42K	–	3419
2022 Q1	$42K	Buy	+100	New	+$5.82K	﹤0.01%	3091

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

HighTower Advisors's LRCX Position: Q2 2026 in Review

HighTower Advisors reduced its Lam Research (LRCX) stake by 5.3% in Q2 2026, selling an estimated $14M and leaving 824,884 shares worth $357M. The position accounts for 0.34% of the portfolio, ranked #55.

HighTower Advisors first reported a position in LRCX in Q1 2014 and has held it in 49 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

HighTower Advisors held 824,884 shares of Lam Research worth $357M as of Q2 2026.
HighTower Advisors sold 45,999 Lam Research shares in Q2 2026, an estimated $14M.
Lam Research made up 0.34% of HighTower Advisors's portfolio in Q2 2026, its #55 holding.
HighTower Advisors first reported a position in Lam Research in Q1 2014 and has held it in 49 quarters since.
3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.